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Abstract
Background: Mammalian cells transform into individual tubular straw cells naturally in tissues and
in response to desiccation related stress in vitro. The transformation event is characterized by a
dramatic cellular deformation process which includes: condensation of certain cellular materials
into a much smaller tubular structure, synthesis of a tubular wall and growth of filamentous
extensions. This study continues the characterization of straw cel l s  i n  b l o o d ,  a s  w e l l  a s  t h e
mechanisms of tubular transformation in response to stress; with specific emphasis placed on
investigating whether tubular transformation shares the same signaling pathway as apoptosis.
Results: There are approximately 100 billion, unconventional, tubular straw cells in human blood
at any given time. The straw blood cell count (SBC) is 45 million/ml, which accounts for 6.9% of the
bloods dry weight. Straw cells originating from the lungs, liver and lymphocytes have varying
nodules, hairiness and dimensions. Lipid profiling reveals severe disruption of the plasma membrane
in CACO cells during transformation. The growth rates for the elongation of filaments and
enlargement of rabbit straw cells is 0.6~1.1 (µm/hr) and 3.8 (µm3/hr), respectively. Studies using
apoptosis inhibitors and a tubular transformation inhibitor in CACO2 cells and in mice suggested
apoptosis produced apoptotic bodies are mediated differently than tubular transformation
produced straw cells. A single dose of 0.01 mg/kg/day of p38 MAPK inhibitor in wild type mice
results in a 30% reduction in the SBC. In 9 domestic animals SBC appears to correlate inversely
with an animal's average lifespan (R2 = 0.7).
Conclusion: Straw cells are observed residing in the mammalian blood with large quantities.
Production of SBC appears to be constant for a given animal and may involve a stress-inducible
protein kinase (P38 MAPK). Tubular transformation is a programmed cell survival process that
diverges from apoptosis. SBCs may be an important indicator of intrinsic aging-related stress.
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Background
We have observed mammalian cells, in a variety of tissues,
transform into individual tubular straw cells in response
to desiccation related stress and also occur naturally in live
blood and tissues [1]. The transformation event is charac-
terized by a dramatic cellular deformation process which
includes: condensation of certain cellular materials into a
much smaller tubular structure, synthesis of a tubular
wall, growth of filamentous extensions, and the intercon-
nection of tubes to form a tubular network. This tubular
transformation occurs constantly and ubiquitously in
every tissue we examined, suggesting that this "distinctive
trait" involves multiple conserved pathways.
Certain features of the tubular transformation resemble
events in apoptosis (the process of programmed cell death
that has been well documented [2-4]). The apoptotic
process begins with a change in the refractive index of the
cell [5] followed by cytoplasmic shrinkage and nuclear
condensation. The cell membrane begins to show blebs or
spikes (protrusions of the cell membrane), and eventually
these blebs and spikes separate from the dying cell and
form "apoptotic bodies". At the biochemical level, DNA
degradation by a specific endonuclease during apoptosis
results in a DNA ladder composed of mono- and oligonu-
cleosomal-sized fragments with 180 base pairs [6]. So far
no mutation in the nematode C. elegans, which has long
been used in studying apoptosis, has been found to dis-
rupt apoptosis completely [7,8], suggesting the presence
of multiple conserved pathways for the same downstream
event.
Caspases constitute a large protein family that is highly
conserved among multicellular organisms. They are con-
stitutively expressed in most cell types as inactive
zymogens that are proteolytically processed before they
gain full activity. Because caspases exist as zymogens, their
activity is thought to be regulated primarily post-transla-
tionally. Inhibition of apoptosis to treat diseases has
shown some success [9-11] using Sphingosine 1-phos-
phate [12] and caspase inhibitors [13-15] in animal mod-
els. Many diseases including cancers, autoimmune
disorders and neurodegenerative conditions, including
Alzheimer's and Huntington's, are believed to be either a
failure of apoptosis to eliminate harmful cells or the inap-
propriate activation of apoptosis, leading to the loss of
essential cells.
The production of straw cells from diseased or stressed tis-
sues could conceivably be associated with loss of organ
function. The accumulation of a filamentous network of
straw cells could also potentially interfere with aspects of
the circulatory system. Therefore we undertook a study to
more fully characterize straw cells in blood, as well as the
mechanisms of tubular transformation in response to
stress. Specifically, we wanted to investigate if tubular
transformation shares the same signaling pathway as
apoptosis. More importantly, the unknown regulation
and the number of molecular players in the tubular trans-
formation signaling pathway provides the potential for
subsequent development of therapeutics to modulate a
variety of human diseases. In fact, we have tested leading
small molecule candidates in a screening program to
inhibit this type of transformation in both cell lines and
in mouse models to help shed light on possible
approaches.
Results
Straw cell morphologies and straw blood cell count (SBC) 
in mice and humans
At least five different types of straw cells can be grouped
according to their size and morphology. These types
include: large straw cells (Figure 1A, first left, from epithe-
lial cells, the curved line is the edge of dried blood drop-
let), small straw cells with short extensions (from
lymphocytes, Fig 1A, middle), straw cells covered with
microscopic hairs (straw cells-C and mice, Figure 1B),
straw cells with a smooth surface (straw cells-A, Figure 1C)
and straw cells stacked with nodules on the surface (Figure
1D, right, from lung cells). In solution straw cells are visi-
ble as virtually round shaped dark dots around 1 µm
(arrows, Figure 1E). The structure of a straw cell is com-
posed of three major parts: the tubular center with a few
filaments and numerous hairs on the surface of filaments
(Figure 1G). Straw cells without extensions are shown in
Figure 1H.
After analyzing blood drawn from the tail artery of young
female mice weighing approximately 30-grams, using 20
mice per experiment in triplicate, we calculated a SBC of
(6.2 ± 1.4) × 106/ml. In human adult male blood, we cal-
culated a SBC of (4.5 ± 1.5) × 107/ml (Table 1). The half-
life of straw cells (disappearance of filamentous exten-
sions) in blood is 20 hrs at 37°C (Figure 1F). Therefore, at
any given time there are approximately 50–100 billion
straw cells, that have transformed from regular cells, in
human blood (based on a total blood volume of 5–8 lit-
ers/person), among which straw cells of lymphocyte ori-
gin (with short extensions) account for 40%.
Straw cell properties
Straw cells have different properties than the rest of the
cells in blood. These cells are extremely hydrophilic and
stay intact in a hypotonic buffer. They have filamentous
extensions that are often covered with numerous micro-
scopic hairs. Depending on their size and the degree of fil-
amentous extensions, they can be separated from the
blood matrix by differential centrifugation and filtration.
Straw blood cells from chickens, dogs, rats, and cattle have
a large amount of filaments compared to those fromBMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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Straw blood cells in air and in solution Figure 1
Straw blood cells in air and in solution. Straw cells originating from mouse, human and other animals. A. Straw cells 
derived from mouse epithelia, lymphocyte, liver and lung cells. B Human filamentous straw cells, C. Human smooth straw cells, 
D. Pig lung straw cells, E. Straw cells in solution; visible dark dots have diameters near 1 µm (arrows). F. Turnover of straw 
cells incubated at 37°C in vitro (▼  Human blood, ▲  Rabbit sera). G. Carton presentation of a straw cell and its components. H. 
Synchronized rabbit straw cells in air. Straw cells losing filamentous extensions were incubated in sterile water at day-0. I. 
Emergence of new filaments at day-1. J. Emergence of rabbit straw cell network in 5 days (dark arrow), emergence of aggre-
gated cell bodies in solution (white arrow). K. Emergence of rabbit regular cells in 6 days, 12 days (L) and 14 days (M). Space 
bar equals to 10 µm.BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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sheep, pigs, and horses. Straw cells from humans, mice,
and rabbits are the least filamentous. When centrifuged,
the hydrophilic interaction with surrounding water keeps
straw cells floating at 10,000 rpm. Naked tubular centers
(straw cells without filaments) precipitate to the bottom
at 5,000 rpm (2, 375 × g). The amount of straw cells in
blood by weight was estimated for 9 mammals and one
bird (Table 1), with a range from 5.2% for sheep to 0.6%
for pigs with an average weight of 3%. The average SBC for
the 9 domestic mammals, along with birds and humans
was 8 million/ml, with humans and rats leading the
counts at approximately 45 and 16 million/ml, respec-
tively.
Elongation of filaments and enlargement of synchronized 
straw cells in vitro
Rabbit straw cells isolated from other cells in the sera by
differential centrifugation with the addition of methanol
(30~50%, depending on the length of filaments for ren-
dering straw cells less hydrophilic) and vortexed vigor-
ously typically lost their fragile filamentous extensions.
When viewed under light microscopy these straw cells
contained only the tubular center with dimensions just
less than 1 µm (Figure 1H). Straw cells isolated from rab-
bit sera stored at -20°C for over one year were incubated
in just sterile water (hypotonic) and they grew new fila-
ments (day 1, Figure 1I). There was a 5-day threshold for
the straw cells to grow back into new generations of fully
viable straw cells (with filaments) as well as regular cells
(arrows, Figure 1J). Based on the number of newly formed
straw cells, these were likely the product of old straw cells
containing just the tubular center, not the result of regular
cells that were left from isolated straw cell populations.
The formation of new straw cells from old straw cells leads
us to believe that straw cells are not only the product of
regular cells but can be formed from other straw cells as
well. Treating straw cells with 4% trichloroacetic acid fol-
lowed by 2 minutes sonication removes their ability to
regenerate.
Synchronized straw cells incubated at 22°C and 37°C in
10% medium (DEME, ATCC) showed a filament elonga-
tion rate of 0.6 µm/hr for the floating straw cells and an
elongation rate of 1.1 µm/hr for those straw cells that were
attached to the bottom of the plate (Figure 1I). The
enlargement of tubular centers attached to the bottom of
the plate, were seen to grow at a rate of 3.8 µm3/hr over
five days. In two weeks, spherical shaped cells derived
from synchronized SBCs without extensions were
observed to occupy the bottom of the 4-well chambers
(Figure 1K, L, and 1M). This regeneration of spherical cells
agrees with our reported observation that CACO2 cells
grow back from straw cells to form regular spherical cells
during the 30-day incubation period [1].
Minute tubes can be seen aggregating around places where
synthesis of new filaments may be happening (Figure 1J).
In the zoom-in view, intact straw cells and long stretches
of filaments are clearly established in day 8 of rabbit sera
incubation. In solution, aggregations of newly emerged
spherical shaped cells are seen (Figure 1K and 1L).
Morphological comparison between apoptotic bodies and 
straw cells
In vitro, transformed straw cells in solution have a typical
apoptosis phenotype in the early stage with the observed
membrane blebbing (Figure 2B, left panel). However, in
the later stages straw cells begin to differ from apoptotic
bodies in the following aspects: (1) they have a continu-
ous tubular structure as opposed to small separate pieces
of lower density; (2) growth of filament extensions are
invisible in solution but become visible when solution is
dry (Figure 2B, right panel); (3) condensation of chroma-
tin in the tubes but not in the remaining cellular debris.
The extensions produced during tubular transformation
are covered with minute microscopic hairs ([1], Fig 2I). In
solution these tubular extensions also appeared to form
an interconnected tubular network ([1], Fig 1C). The com-
pletion of the tubular transformation is marked by the
Table 1: Straw blood cell properties.
Animals & Human SBC (million/ml) Blood D. W. (mg/ml) %Straw Cell (% Dry W.) Body Weight* (kg) Lifespan** (Year)
Mouse (Mus musculus) 6.2 138 1.6 0.03 1.3
Rats (Rattus norvegicus) 16 210 2.7 0.485 3
Rabbit (O. cuniculus) 3.5 151 4.3 2.7 5
Chicken (Gallus gallus) 3.2 243 2.4 2.9 8
Dog (D. andersoni) 1 182 1.0 9 11.5
Sheep (Ovis aries) 4.4 169 5.2 50 12
Pig (Sus scrofa) 0.6 171 0.6 68 9.5
Human (Homo sapiens)4 5 2 2 9 6 . 9 7 5 7 5
Cow (Bos taurus) 1.4 114 2.3 272 10
Horse (Equus caballus) 2 177 2.1 544 20
* Body weight was from measurement of individual animals; **lifespan uses average animal lifespan taken from literature.BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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Production of straw cells in vitro Figure 2
Production of straw cells in vitro. Straw cells from dehydration induced CACO2 cells in vitro. A. Normal CACO2 cells, B. 
SC filaments in solution and in air, C. Surface and total lipids from normal and induced cells.BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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separation of the discarded plasma matrix from the tube.
In apoptosis, the early stages and late stages are marked by
an increase in caspase activity, PRPP cleavage, and con-
densation of chromatin.
The exposure of phosphatidylserine (PS) on the cell sur-
face is a general marker of apoptotic cells [16]. Cell surface
lipids in transforming cells were analyzed by mass spec-
trometry and compared to controls of surface and total
lipids in regular cells. Lipid profiling reveals that tubular
transformation is a dramatic deformation process. During
deformation, the integrity of the plasma membrane is
altered so much that free fatty acids, FA 16:0 (255.23 [M-
H]-1) and FA 18:0 (283.26 [M-H]-1) which were absent
from the outer leaflet in controls, were detected on the
transforming cell's surface. However, changes of phos-
phatidylserine species, such as PS 36:1 (811.534 m/z),
were inconclusive between treatment and controls.
Signaling pathway comparison between apoptotic body 
and straw cell
Despite some morphological similarities to apoptosis, the
tubular transformation is likely regulated by different
pathways in producing the final product. When straw cells
are mostly transformed (>90%) no DNA ladder was
observed (Figure 3A, left panel). Compared to dehydra-
tion conditions which produced no straw cells but instead
produced mostly apoptotic bodies (<10% transformation
in 1.5× medium), a DNA ladder was observed (Figure 3A,
right). Observation of this DNA ladder indicates that in
tubular transformation DNA molecules are translocated
entirely, opposite to that in apoptotic bodies where DNA
molecules are degraded. Caspase 3/7 activity during a suc-
cessful tubular transformation decreased with the dehy-
dration time (Figure 3B), whereas in apoptosis caspases 3/
7 activities increase. In addition, caspase inhibitor (Q-VD-
OPh) exerted no inhibition in tubular transformation in
vitro/vivo either alone or in combinations with other apop-
tosis inhibitors. At 2 mg/kg body weight, it had no inhib-
itory activity against tubular transformation and the
number of straw cells in vivo was not changed compared
to controls (Figure 3C and Table 2). A ceramide antago-
nist, sphingosine 1-phosphate, competing for ceramide
mediated apoptosis, had no activity in vivo at 1 mg/kg
body weight/day and in vitro at 200 ppm (Figure 3C, Table
2). Collectively, several lines of evidence suggest that the
pathway that leads to tubular transformation in straw cell
production diverges from that of apoptosis in apoptotic
body production, at least in the late stage. However, the
molecular players involved in the signal transduction
have not been identified, but the signals are very likely to
start at plasma membrane. Study by exerting osmotic
stress with PEG (10%), which causes cells to shrink and
plasma membranes to separate from the rest of the cell
bodies, interrupts the signal and produces no tubular
transformation [1].
SBC may play a role in animal aging
From nine animals (mouse, rat, rabbit, chicken, dog,
sheep, pig, cow, and horse) SBCs are found to correlate
with the animal's average lifespan in an inverse relation-
ship with the coefficient of correlation R2 = 0.7 (Table 1,
Figure 4). Animals with more straw cells have shorter life
spans, suggesting SBC may measure an intrinsic stress
level specific to each animal. It was noticed that straw cell
production/day/body weight appears independent of age
of a given species (data not shown), which agrees with the
notion that aging starts at birth and continues at a con-
stant pace [17]. The direct connection between straw cells
and the lifespan of an animal suggests that the production
of straw cells may cause a loss of cell/organ function in
individuals. We speculate this accumulation of straw cells
along with the loss of cell/organ function may play a role
in many aging related diseases and eventually lead to the
death of the individual.
Inhibition of a stress inducible MAPK reduced straw cells in 
vitro/vivo
P38 MAPK inhibitor interrupts an environmental stress
signal from the cell surface to the nucleus via inhibition of
P38 kinase activity. In addition to its promising anti-
inflammatory usage [18], we found that it may be
involved in the straw cell development pathway. Admin-
istration of 0.01 mg/kg body weight/day in vivo and 10
ppm in vitro, of a pyridinyl imidazole (SB 202190), which
inhibits an inducible P38 MAPK, reduced mice SBC by
Table 2: Inhibition of tubular transformation by small molecules.
CACO2 Mouse Note
Inhibitors µg/ml (ppm) Tubular T. (Morphology 
And count)
mg/kg/day (ppm/day) SBC (%) Reduction Mode of action (References)
Sphingosine-1-phosphate 200 no inhibition 1 no change compete for ceramide 
mediated apoptosis [12]
Q-VD-OPh 200 no inhibition 2 no change compete for caspase 
mediated apoptosis [9, 13]
Pyridinyl Imidazole 10 > 90% inhibition 0.01 30 bind to a P38 MAPK Kd = 38 
nm [18]BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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30% (p = 0.003) in double blind, triplicate experiments
with both the test and control using over 20 individual
mice. The effects of treatment by three small molecular
inhibitors together with controls on SBC are given in Fig-
ure 3C (with means and errors) and Table 2. The P38 MAP
kinases are a family of serine/threonine protein kinases
that play important roles in cellular responses to external
stress signals [18]. The resulting reduction in SBC from a
treatment with a single dose of SB 202190 suggests that
the protein kinase cascade, mediated through IL-1, TNF,
IL-18 to MEKK1, 3, NIK, to MKK3, 6 plays a role in tubular
transformation.
Identification of protein involved in the tubulargenesis and 
regeneration
After performing multiple purifications using two types of
cancer cell lines, we have purified a unique protein from a
culture medium containing an abundance of filaments
and bovine albumins (Figure 5). We then performed de
novo peptide sequencing using a data-dependent acquisi-
tion method from digestions of samples with trypsin and
chymotrypsin as well as peptide mapping using tryptic
peptides and high stringency scores (ladder score and E-
value). Using these methods we have tentatively identi-
fied a match to a human 57 KD protein known to be a
component of the walls of ciliary and flagellar microtu-
bules (Tektin-3, [19]). During regeneration of regular
spherical cells from straw cells, three proteins at 52, 57
and 63 KD appear to be abundantly expressed in the early
stages of this regeneration (Figure 5, 1B). Micro-sequenc-
ing and peptide mapping using tryptic peptides found sig-
nificant alignment with 80% coverage to a human 57 KD
protein (hypothetical, Q8NDG0).
Discussion
Mammalian blood contains three visible layers when cen-
trifuged. The plasma forms at the top, accounting for
~55% of the volume, then a thin cream-colored layer
forms below the plasma consisting of white blood cells
and platelets, followed by a final layer consisting of red
Comparison of tubular transformation with apoptotic bodies Figure 3
Comparison of tubular transformation with apop-
totic bodies.A. No appearance of DNA ladder (left panel) 
in CACO2 cells during a successful tubular transformation 
induced by dehydration. DNA ladder did appear (right panel) 
in CACO2 cells during a failed tubular transformation B. 
Measurement of caspase-3/7 activity during dehydration 
induced tubular transformation in CACO2 cells. C. Inhibition 
of tubular transformation by small molecules in vivo. Blood 
samples are counted from a single dose sc at 24 hr.
The relationship between SBC and expected animal lifespan Figure 4
The relationship between SBC and expected animal 
lifespan. The Figure is plotted using data from Table 1.BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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blood cells, forming the heavy bottom portion of the sep-
arated mixture, which accounts for ~45% of the volume
[20]. We found straw cells in both the plasma and the bot-
tom layer when centrifuged. The tubular centers are
densely packed and heavy. When their filament exten-
sions are lost, they are found in the bottom layer with
other lysed cell debris. However, when the filaments are
intact, the straw cells remain within the supernatant, even
when centrifuged at maximum speed (13,000 rpm or
16,060 × g) on a bench-top centrifuge. At 45 million cells
per ml, they account for ~7% of dry mass in human
blood.
We compared two methods in straw cell counting: (1) use
a Hemacytometer and count the number of dark dots
around 1 µm in a defined volume in solution without any
distortion to the blood samples and (2) count tubular
straw cells from 1 µ of dried blood droplet on cover glass
slide directly. We found the numbers derived from two
different methods (in solution vs. in air) are in surpris-
ingly good agreement to each other. This agreement sug-
gests that no artifacts were introduced in the counting
process and SBCs reflect their actual blood content.
Straw cells occur naturally and at a constant rate in the
humans and animals we tested. SBC from nine domestic
animals correlates directly to the animal's average
expected life span, suggesting a simple connection
between tubular transformation and the amount of cells
needed to sustain life. In the animals tested, there was an
inverse relationship between SBC and the average lifespan
of those animals (Figure 4). However, humans appear to
have high SBC levels but our average expected lifespan is
much higher than the animals we tested and therefore
does not fit the trend observed in Figure 4. Perhaps
humans, and possibly other primates, exhibit a higher tol-
erance to elevated SBC levels.
Straw cells may be involved in a variety of human aging-
related diseases; for example, invasive malignant tumors
contain no distinct boundary between healthy tissue and
irregularly shaped cancer cells. Current cancer treatments
such as chemotherapy and radiotherapy enhance tumor
apoptosis, causing these cancerous cells to transform into
apoptotic bodies [21-23]. The strategy of increasing tumor
apoptosis is currently being employed in many cancer
treatments [24,25]. Our findings predict that this physical
and chemical stress not only induces apoptosis but also
produces viable straw cells. Straw cells and apoptotic bod-
ies may be the co-products of the same upstream stress
responding pathway. We have observed that a DNA lad-
der, a hallmark of apoptosis, accompanies the tubular
transformation (Figure 3A). The hydrophilic nature of
straw cells also allows them to flow freely into the blood
circulatory system. In vitro, straw cells originating from
both normal cells and cancer cells germinate and grow
back into vegetative cells within a few days to a few weeks.
In general, after the remission of the original cancer, the
recurrence of tumors in cancer patients frequently occurs
within 2~3 years after initial treatments[26,27].
We hypothesize that vast numbers of free circulating can-
cerous straw cells in blood are capable of regenerating
back into actively growing tumor cells at new locations.
These circulating straw cells provide a possible mecha-
nism for the establishment of new sites in the body for
tumorgenesis. The possibility for straw cells to colonize
and grow into tumors may be very small, depending upon
the availability of nutrients, DNA mutations, and interac-
tions with the host immune system. However, due to the
large number of straw cells present within the blood circu-
latory system, metastasis could still very well be mediated
through straw cells that are produced from increasing
physiochemical stresses within a fast growing tumor mass.
The straw cells robust cell wall [1] may allow them to tol-
erate the harsh conditions provided by radiation and
chemotherapy. Enabling the straw cells to remain viable
even after the original cancer cells, die off (i.e. remission
in cancer patients). Cancerous straw cells would then be
able to propagate when growth conditions improve in
vivo.
Since apoptosis was coined in the 1950s, it is believed that
programmed cell death is important in keeping cell
homeostasis, organ development, and maintaining
Identification of proteins involved in tubular transformation  and regeneration Figure 5
Identification of proteins involved in tubular transfor-
mation and regeneration.A. Purified tubular proteins on 
SDS/PAGE in10% acrylamide gel from MCF-7 and CACO2 
cells that were transformed into straw cells. B. Regeneration 
of regular cells from straw cells, three proteins at 63, 57, and 
52 KD were abundantly expressed in the early stage of the 
process.BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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proper cell population. Although diseases are attributed
to abnormal cell death, targeting cancer cells with pro-
moters of apoptosis is an active route of treatment. It is
possible that current approaches to cancer treatment
involving chemotherapy may contribute to metastasis.
Although numerous chemotherapy treatments have been
implemented (taxanes, vincas, herceptin, kinase inhibi-
tors, etc.) and they have saved many lives, the delay of a
major breakthrough over controlling the disease may be
due to the misleading idea that cells die through apopto-
sis. Where in fact, a portion of the targeted cells enters into
a straw cell survival state through "apoptosis" associated
stresses to survive and propagate.
We counted the number of straw cells derived from lym-
phocytes (T and/or B cells) in human blood with charac-
teristic short filamentous extensions to be consistent with
the number of lymphocytes that die per day through
apoptosis (~50 billion). The SBC in humans is around
45,000/µl, 40% of which are smaller straw cells character-
istic of lymphocytes. With a half-life of 20 hr in blood cir-
culation, an estimated 100 billion of all cells are
transformed into straw cells every day. Injection of 0.3 µg
subcutaneously of a specific protein kinase inhibitor to a
30-gram mouse (equivalent of 1.2 mg to 85 kg person)
resulted in a 30% reduction in SBC in the tail artery over
48 hrs. It is unclear if a 30% SBC reduction in mice could
be translated to Humans; more studies are needed to
make the distinction. The important questions that
remain to be answered are: (1) Characterization of the
upstream regulatory pathways that promote straw cell for-
mation, 2) Can treatments associated with straw cell
reduction significantly improves overall health and lon-
gevity? 3) Can straw cell treatment reduction also be an
effective way to reduce the spread of tumors in conjunc-
tion with other types of treatments?
We have identified one protein involved in the biogenesis
of straw cells from the cleavage of purified tubular exten-
sions. This protein can then be targeted for straw cell inhi-
bition, for example, pyridinyl imidazole inhibits the
tubular transformation at 10 ppm in vitro and 0.01 mg/kg
BW/day in vivo by inhibiting a stress inducible protein
kinase, which may be an early event in the signal trans-
duction.
Conclusion
Mammalian cells transform into individual tubular straw
cells naturally in live blood and tissues in animals and
humans, and also in response to increased stresses in
CACO2 cells. The transformation event in CACO2 cell is
characterized by a dramatic cellular deformation process
which includes: nuclei fragmentation and packaging of
chromatin into a much smaller tubular structure, synthe-
sis of a tubular wall, growth of filamentous extensions,
and the interconnection of tubes to form a tubular net-
work. This tubular transformation occurs constantly and
ubiquitously in every tissue we examined, suggesting that
this "distinctive trait" involves multiple conserved path-
ways. Certain features of the tubular transformation
resemble events in apoptosis suggesting straw cells may
have been studied for decades as products of programmed
cell death while in fact they are the products of "pro-
grammed cell survival". SBCs may be an important indi-
cator of intrinsic aging-related stress.
Methods
Pyridinyl imidazole (SB 202190) was purchased from
Sigma (St. Louis, MO) Ceramide antagonist, sphingosine
1-phosphate was purchased from Fisher Scientific (Pitts-
burgh, PA). Caspase inhibitor, Q-VD-OPh was purchased
from MP biomedical (Solon, OH). DNA ladder assay kit
was purchased from Roche-Applied-Science (Indianapo-
lis, IN).
Blood samples were drawn from young and healthy ani-
mals. Female wild type mice, Balb/c, Swiss Webster,
between 31–34 g at 120-day-old were purchased from
Harlan (Indianapolis, Indiana), Sprague-Dawley rat
weighing between 300 – 350 grams at 5.5-month-old
were purchased from Harlan (Madison, Wisconsin). SC).
Fresh blood samples from Chicken (Gallus gallus, 6 to 8
weeks at 5 to 8 pounds), Sheep (Ovis aries, 2–3 years at
110 lb), Quarter Horse (Equus caballus, 10 years at 1200
lb) were collected from animal farm via Godley-Snell
Research Center (Clemson University, SC), Pig (Sus
scrofa, 1–2 years at 150 lb) and Cattle (Bos taurus, 1–2
years at 600 lb) from the meat processing lab (Seneca,
SC), Dog (D. andersoni, 6 months at 20 lb) from Clem-
son animal hospital (Clemson, SC), human (Homo sapi-
ens, adults at 160 to 220 lb) from Oconee memorial
hospital (Seneca, SC). Rabbit sera were prepared by Cocal-
ica Biologicals, Inc. (Reamstown, PA). Bovine liver was
purchased from Bi-Lo grocery store (Clemson, SC). All
blood samples were from healthy animals and humans.
Cell culturing used DEME medium supplemented with
20% fetal bovine serum (FBS, ATCC) in culture flask in a
CO2 incubator at 37°C. Chemicals used were from Sigma-
Aldrich Company (St. Louis, MO).
Straw Blood Cell Count (SBC)
Determining SBC used both an in-solution and an in-air
method. In solution, a Hemacytometer (SPotlite, Baxter
Healthcare Corporation) was used to determine SBC
straw cells; visible dark dots with diameters around 1 µm
were counted and five random squares were used to aver-
age the counts. In the in-air method, 1 µl of dried aliquot
placed on a glass slide was used to estimate the SBC count.
The numbers from both counts were expressed in SBC/ml.
They typically agree with each other within a 10% varia-BMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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tion. Fresh mouse and human blood samples, along with
ten domestic animals were collected and their subsequent
SBC straw cells were immediately determined. Blood sam-
ples (264) from 88 mice were counted SBC and averaged.
Blood samples from the human frontal arm peripheral
veins were used. For other domestic animals, multiple
samples (varies from species to species, but at least three
samples in each case) were analyzed using 1 µl of blood
sample as is, or diluted in 1:10 distilled water to avoid red
blood cells in the field. Duplicate readings from each
blood sample were averaged and reported.
Lipid profiling
Lipid profiling by ESI mass spectrometry in negative ion
mode uses published protocol [28] Nano-electrospray
ionization tandem mass spectrometry (nano-ESI-MS/MS,
Q-Tof, Waters) was employed to determine qualitative
differences in the lipid molecular species composition
between CACO cells undergoing tubular transformation
and controls. Lipids were extracted using 200 µl chloro-
form: methanol = 1:1 to 125000 cells in a four-well cham-
ber that were pre-washed with 1 × PBS to remove any
residual lipids from medium. For surface lipids, cells were
frozen at (-80°C) and extracted with cold solvents (-
20°C) quickly. Four chambers of resulting solvents were
combined and concentrated down to 50 µl; NH4OH was
added to a final 1% solution. For total lipids, cells at room
temperature (22°C) were treated with chloroform: meth-
anol: H2O = 1:1:1 (200 µl), sonicated and centrifuged.
The bottom chloroform phase was collected, combined,
and concentrated down to 50 µl. NH4OH was added to
make a final 1% solution. Acquisition of lipid species
used 1 µl sample injected directly to ESI-MS in negative
ion mode with a mass scanning range from 200 – 1200 m/
z.
Straw blood cell content
Blood and purified SBC straw cells (mouse, rat, rabbit,
chicken, dog, sheep, pig, human, cow, and horse) were
estimated for total dry weight by drying out each sample.
One ml of sample was dried under a vacuum concentrator
(CentriVap concentrator, LABCONCO) until a constant
weight was reached. Percentage of straw cell dry weight
was estimated by both extraction and filtration methods.
First, the sample was centrifuged at 13,000 rpm for 3 min
and the supernatant was vortexed twice at 1 min each to
break the filaments from the tubular center. The resulting
straw cells were centrifuged at 13,000 rpm for 3 min
again. Pellets were washed and combined with blood that
was extracted twice, using a 1:1:1 solution of chloroform:
methanol: water. Next, the top water layer containing
straw cells was passed through a 100 KD microconcentra-
tor (Microcon, Amicon) at 5000 rpm for 40 min, twice.
Finally, the retained fraction was then loaded on a C18
spin column (Sep-Pak Cartridges, C18 1 cc, Waters) to
remove remaining soluble material.
In the filtration method, straw cells were purified using a
nitrocellulose membrane. First, whole blood aliquots of
0.5 ml were diluted to 2 ml in distilled water to lyse the
regular cells. The sample was then centrifuged to remove
cell debris. When blood samples were centrifuged at
10,000 rpm (9530 g) for 3 min, the filamentous tubes
moved to the bottom and separated from the naked tubes
on top. The tubes without extensions were the densest cel-
lular material, pelleting to the bottom at 5,000 rpm. The
aggregated pellet was then washed three times with dis-
tilled water. The resulting supernatant, containing straw
cells, was combined with previous straw cell fractions and
placed in a syringe and pushed through a 0.025 µm nitro-
cellulose membrane filter (VSWP, Millipore). The amount
of soluble material remaining in each passage is governed
by (1/4)n. Theoretically, the amount of soluble material
retained equals 0.02% of starting material when n = 6,
which becomes negligible when calculating the dry
weight. The n = 8 retained fraction was dried to comple-
tion and washed in 80%, cold ethanol (4°C) twice to
remove remaining proteins. The resulting dry matter, cal-
ibrated by OD 280 nm for protein content was used to
estimate the straw cell content. Most rabbit straw cells
flow through 0.1 µm membrane (polycarbonate, Solution
Consultants®).
Elongation, enlargement and half-life in vitro
Straw cells were synchronized by removing filaments
from the tubular center when vortexed in 30% methanol.
The straw cells without extensions were collected and
placed in 4-well chambers and incubated in 0.1× medium
at 37°C. Measurement of newly elongated filaments
under light microscope was calculated from ten randomly
selected straw cells and measured length in 24 hr intervals
over 72 hrs. The results were averaged by total number of
hours to give the growth rate in µm/hr. Growth of CACO2
straw cells to regular spherical cells used a synchronized
tubular center and measured cell diameters in a 5-day
time frame. The results were averaged by the total number
of hours to give the growth rate in µm3/hr. The experi-
ments were repeated three times. The half-life of straw
cells is defined as the loss of the filamentous structure in
vitro incubated at 37°C.
Cell-based assay in 96-well
Compounds mostly insoluble in water were dissolved in
medium with help of DMSO, palmitic acid and phospho-
tidyl choline (PC 36:0) through lipid vesicle hydration
methodology [29,30]. Sonication was used to facilitate
the solubilization. Lipids in the medium also help solubi-
lizing organic compounds. A known amount of chemical
was tested on (1) dehydration induced CACO2 tubularBMC Cell Biology 2008, 9:26 http://www.biomedcentral.com/1471-2121/9/26
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transformation [1] and (2) germination and elongation of
CACO2 straw cells. For measuring the inhibitory activity
of screening compounds quantitatively, a colorimetric
reaction in 96 well format was used that measures the
absorbance of total proteins and reducing sugars in THP1
cells that correlates to the amount of intact cells protected
from tubular transformation undergoing dehydration
treatment. For germination assay, spore-like straw cells
were harvested and diluted 10 times in the growth
medium and stored at -20°C, 5 ml aliquot of the stock
was used for each 96 well plate with 50 µl in each assaying
well.
Preparation of testing molecules in lipid micelle and 
efficacy study in mice
Injection vehicles were prepared using protocols from the
literature [29,31]. Test compounds (a caspase inhibitor, a
ceramide antagonist and a pyridinyl imidazole) and pla-
cebo (lipid vehicle alone) in various doses were made in
100× stock solution in 1.2 mM palmitate, or PC 36:0 in 1
× PBS solution. Samples were coded randomly. Precondi-
tioned mice (wild type Balb/c, Harlen) were injected sub-
cutaneously with 100 µl of the working solution in 1 ×
PBS. Blood samples from the tail artery in 5 µl samples
were drawn at 0, 24, 48, 72 hr after a single dose. Control
(with only injection vehicle) and test samples in doses
0.1, 1 and 10 µmole were injected with 4 mice in each
group. The experiment was repeated three times.
Each blood drawing sample containing 5 µl was immedi-
ately placed in a collection tube coated with anti-coagu-
lant and diluted in distilled water to 50 µl. Aliquots of 1
µl were placed on a glass slide, dried and counted. The
results were analyzed by a Student's T-test (two tailed,
equal variance), where means between test and control
groups were compared for significance.
Light microscopy
Cell imaging uses protocol described in the reference [1].
DNA extraction and Caspase assay
DNA extraction used a protocol described by the manu-
facturer (Roche Applied Science with modifications.
Briefly, 0.5 million cells were harvested and combined in
the lysis buffer and combined to have a final volume of
400 µl (200 µl cell plus 200 µl lysis buffer). The final prep-
aration was digested with RNase (RNase A, Ambion) for
30 min at 37°C to remove RNAs bound to the DNA filter.
The eluted fraction was concentrated to 30 µl and used 6
µl for DNA electrophoresis. Caspase-3/7 activity was
measured according to the manufacturer's menu (Apo-
One® homogeneous caspase-3/7 assay, Promega (Madi-
son, WI).
Protein purification and characterization
Protein purification and characterization used the proto-
col described in the reference [1]. Synchronized straw cells
were incubated in 1× RPMI-1640 medium supplemented
with 20% FBS for two weeks at 37°C in a CO2 incubator,
cells were detached with 0.5% Trypsin at 37°C for 30 min-
utes. Precipitated cells were dissolved in reducing SDS
sample buffer (2 ×) and separated in 10% acrylamide gel
at 220 volts. The gel bands were processed by the in-gel
tryptic digestion procedure and micro-sequenced by the
DDA method (Masslynx, Waters (Milford, MA). Peptide
mapping used tryptic peptides by GPMAW software.
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